Please wait.........
As per the decision of the Editorial Board meeting held on 28th December 2022, from February 2023 onwards, all the Postgraduate members will receive E copy of the JAPI as a Go-Green initiative. The physical copy / Hard copy of a particular issue will be provided to the member with a special request sent from the registered email ID to the JAPI office. Important Message to API Members click here to read

Indian Hypertension Guidelines-II

PREAMBLE
LIST OF MEMBERS
DEFINITION AND CLASSIFICATION
Definition
Classification
EPIDEMIOLOGY
MEASUREMENT OF BLOOD PRESSURE
Clinic Measurement
Home Measurement
Ambulatory Blood Pressure Monitoring
EVALUATION
Medical History
Physical Examination
Laboratory Investigations
Factors Influencing Risks and Risk Stratification
MANAGEMENT OF HYPERTENSION
Goals of Therapy
Management Strategy
Non-pharmacologic Therapy
  – Principles of diet in hypertension
Pharmacologic Therapy
  – Principles of drug treatment
  – Antihypertensive drugs
  –– Diuretics
  –– Beta-blockers
  –– Calcium channel blockers (CCBs)
  –– Angiotensin converting enzyme inhibitors (ACE inhibitors)
  –– Angiotensin II receptor blockers (ARBs)
  –– Alpha-blockers
  –– Other drugs
  – Antihypertensive drug combinations
Drug Interactions
Maintenance and Follow-up of Therapy
Adverse Drug Reactions
Associated Therapies
SECONDARY HYPERTENSION
Prevalence
Presentation
Important Causes
COMPLICATIONS
HYPERTENSION IN SPECIAL SITUATIONS
Hypertension with Diabetes Mellitus
Hypertension with Renal Disease
Hypertension with Cerebrovascular Disease
Hypertension in Women
Hypertension in Pregnancy
Hypertension in the Elderly
Isolated Systolic Hypertension
Hypertension with Congestive Cardiac Failure
Hypertension with Chronic Obstructive Airway Disease
Hypertension with Coronary Artery Disease
Hypertension with Dyslipidemia
Hypertension with Obesity and Metabolic Syndrome
Resistant Hypertension
Hypertensive Crises
REFERENCES